Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma

The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

Wallace H. Clark, Lynn From, Evelina A. Bernardino et al. · PubMed · 1969 · 2.1K citations

Medicine, Dermatology, Pathology +17

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

Antônio C. Buzaid, Merrick I. Ross, Charles M. Balch et al. · Journal of Clinical Oncology · 1997 · 303 citations

Medicine, Dermatology, Oncology +17

Clinical significance of serum S100 in metastatic malignant melanoma

Hua Guo, Birgit Stoffel‐Wagner, T. Bierwirth et al. · European Journal of Cancer · 1995 · 157 citations

Medicine, Oncology, Pathology +16

Serum S-100B Protein as a Prognostic Marker in Malignant Cutaneous Melanoma

E. Djureen Mårtenson, L.‐O. Hansson, Bo Nilsson et al. · Journal of Clinical Oncology · 2001 · 113 citations

Medicine, Dermatology, Oncology +17

Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma

C.S. Jury, E J McAllister, R. M. MacKie · British Journal of Dermatology · 2000 · 90 citations

Medicine, Dermatology, Oncology +17